Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Egalet Corp (EGLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,788
  • Shares Outstanding, K 56,770
  • Annual Sales, $ 26,140 K
  • Annual Income, $ -69,360 K
  • 36-Month Beta 0.64
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +54.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0310 +1.61%
on 10/31/18
0.1580 -80.06%
on 10/05/18
-0.0926 (-74.62%)
since 09/28/18
3-Month
0.0310 +1.61%
on 10/31/18
0.6800 -95.37%
on 08/07/18
-0.2465 (-88.67%)
since 07/30/18
52-Week
0.0310 +1.61%
on 10/31/18
1.5700 -97.99%
on 11/16/17
-0.9685 (-96.85%)
since 10/30/17

Most Recent Stories

More News
Egalet Reports Third Quarter 2018 Financial Results

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain, today reported financial...

EGLT : 0.0315 (-63.37%)
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products

Egalet Corporation (OTCQX: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain, today entered into an...

EGLT : 0.0315 (-63.37%)
Egalet Reports First Quarter 2018 Financial Results

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.0315 (-63.37%)
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.0315 (-63.37%)
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER

WAYNE, Pa. , May 7, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative...

EGLT : 0.0315 (-63.37%)
Egalet to Present at the 3rd Annual Disruptive Growth & Healthcare Conference

WAYNE, PA / ACCESSWIRE / May 2, 2018 / Egalet Corporation (NASDAQ: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments...

EGLT : 0.0315 (-63.37%)
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions,...

EGLT : 0.0315 (-63.37%)
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,...

EGLT : 0.0315 (-63.37%)
Factors of Influence in 2018, Key Indicators and Opportunity within Clifton, CSG Systems International, ArcelorMittal, Denny's, Yamana Gold, and Egalet -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clifton Bancorp Inc. (NASDAQ:CSBK),...

CSGS : 35.22 (-0.25%)
AUY : 2.31 (-4.94%)
CSBK : 15.65 (+0.45%)
MT : 22.63 (+2.26%)
EGLT : 0.0315 (-63.37%)
DENN : 18.16 (+0.55%)
Data Shows That the Global Addiction Treatment Market is Set to Grow

Data provided by Transparency Market Research, indicates that global addiction treatment market was valued at approximately US$ 4.0 billion in 2016 and is anticipated to expand at a CAGR of over 6.0% from...

BICX : 0.0890 (+2.30%)
DRRX : 0.58 (-3.33%)
TTNP : 0.23 (unch)
BDSI : 4.32 (+0.93%)
EGLT : 0.0315 (-63.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EGLT with:

Key Turning Points

2nd Resistance Point 0.1232
1st Resistance Point 0.0773
Last Price 0.0315
1st Support Level 0.0083
2nd Support Level 0.0000

See More

52-Week High 1.5700
Fibonacci 61.8% 0.9821
Fibonacci 50% 0.8005
Fibonacci 38.2% 0.6189
Last Price 0.0315
52-Week Low 0.0310

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar